ENDRA Life Sciences Inc

NAS:NDRAHealthcarenasdaq_composite

$4.75+0.21%At closeAt close · Tue 20 Oct · ≈ AED 17.44 · Market cap $7.12M · Next earnings Fri 13 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	−163.6%	−104.1%	−182.9%	−177.8%	−449.5%	−310.9%	−310.9%	+0.0 pts
Return on assets	−133.8%	−87.2%	−142.1%	−148.9%	−258.5%	−182.4%	−182.4%	+0.0 pts
Return on capital employed	−147.9%	−101.5%	−173.8%	−179.8%	−281.2%	−185.7%	—	—
Debt / equity	0.1×	0.1×	0.1×	0.1×	0.3×	0.2×	0.2×	+0.0%
Debt / assets	8.8%	6.2%	5.9%	5.8%	16.9%	12.8%	—	—
Interest coverage	−49.5×	0.0×	−611.0×	0.0×	0.0×	0.0×	—	—
Current ratio	8.3×	7.8×	5.0×	3.4×	5.7×	1.3×	1.3×	+0.0%
Quick ratio	7.7×	7.0×	3.5×	3.4×	5.7×	1.3×	—	—
Cash ratio	7.3×	6.1×	2.9×	3.1×	5.3×	1.0×	1.0×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Inventory turnover	0.0×	0.0×	0.0×	—	—	—	—	—
Dividend payout	−3.4%	−1.1%	−0.1%	−0.0%	−0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.